EcoDrugPlus

Estrogen Receptor 1

Ensembl ID : ENSIPUG00000019477
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSIPUG00000018308
Gene Symbol: ESR2A
2 Cross references
198 Possible Orthologues:

Estrogen Receptor 2b

Ensembl ID : ENSIPUG00000023204
Gene Symbol: ESR2B
3 Cross references
210 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSIPUG00000014295
Gene Symbol: ESRRGA
3 Cross references
153 Possible Orthologues:

Exportin 1 (Crm1 Homolog, Yeast) A

Ensembl ID : ENSIPUG00000024394
Gene Symbol: XPO1A
3 Cross references
222 Possible Orthologues:

Exportin 1 (Crm1 Homolog, Yeast) B

Ensembl ID : ENSIPUG00000012891
Gene Symbol: XPO1B
3 Cross references
157 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSIPUG00000008338
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSIPUG00000007144
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSIPUG00000020862
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSIPUG00000019260
Gene Symbol: FNTB
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A

Ensembl ID : ENSIPUG00000008062
Gene Symbol: LOC108265400
4 Cross references
205 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSIPUG00000015084
Gene Symbol: FGFR2
3 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).